# Reappraisal of GIK in Acute STEMI by Pre-hospital Administration

> **NCT02591927** · PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 334 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Glucose-Insulin-Potassium
- **DRUG:** Glucose 5%

## Key facts

- **NCT ID:** NCT02591927
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2019-02
- **Final completion:** —
- **Target enrollment:** 334 (ESTIMATED)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02591927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02591927, "Reappraisal of GIK in Acute STEMI by Pre-hospital Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02591927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*